Skip to main content
search
0
COMPANY

We are a GMP-certified pharmaceutical company based in Montego Bay, Jamaica

Meet The Leadership Team

We're a dynamic multidisciplinary team of business leaders and scientists with a passion for helping to improve global human health.

Director, Co-Founder & CEO

Scott Cathcart

Scott relocated from the US to Jamaica full time to lead the development of Seven-10 Pharmaceuticals. He is a serial entrepreneur and former Ogilvy, BBDO and J. Walter Thompson ad exec on large, multinational CPG brand accounts such as Nestle, Gillette and Kimberly-Clark. A cannabis testing pioneer at Steep Hill Labs, Scott has also served as an executive strategist to cannabis businesses in multiple US States, Canada, and Mexico, and he has served as a pro bono legislative and regulatory advisor to COFEPRIS (the Mexican Government’s health regulator) and the Minister of Justice of Jamaica. In addition to managing the Gillette account in the US, Canada and 17 European markets for advertising agency BBDO in NYC, as the new products team lead Scott drafted the global strategic platform that Gillette followed to launch the replacement for the Sensor franchise, leading to the most successful razor launch in history, the Gillette Mach3.
Director, Chief Regulatory & Compliance Officer

Ellen Campbell Grizzle, Ph.D., R.Ph.

Dr. Grizzle has been a registered pharmacist for more than 50 years, and she is formerly a 30-year Member of the Board of the Pharmacy Council of Jamaica, the Caribbean Pharmacist of the Year, General Manager of an Abbott Labs subsidiary in Jamaica, Researcher of the Year for the Caribbean Institute of Pharmacy Policy Practice and Research, and former Dean of Heath Sciences at the University of Technology, Jamaica (UTech).
Director, Chief Financial Officer

Mirsad Jakubovic

Mirsad was Chief Financial Officer for 48 North Cannabis (f/k/a Delshen Therapeutics), the 39th “LP” (Licensed Producer) of cannabis in Canada, and he oversaw the construction of its cannabis production facility and its approval as a Licensed Producer under Health Canada’s Cannabis Act.
Chief Scientific Consultant

Donald Land, Ph.D.

Dr. Land is a tenured professor at U.C. Davis and one of the world’s leading scientists in the field of cannabis and cannabis-derived products. Dr. Land oversees isolation and purification research and product chemical testing. He received his doctorate in chemistry from UC Irvine in 1989, pursued an Alexander von Humboldt Fellowship in 1990 at the Research Center, Juelich, Germany, and was hired as a professor of chemistry at UC Davis in 1991 where he applied mass spectrometry and electron and optical spectroscopies to interfacial systems. He is also a member of the forensic science and the biotechnology graduate groups at UCD, serves on the Steering Committee for the UCD Cannabis and Hemp Research Center, and also serves as an expert witness in civil and criminal matters. In 2010, he co-founded Halent Laboratories (Sacramento), an early cannabis testing lab which merged with Steep Hill Labs (Berkeley) in 2013. In 2020, Dr. Land was voted the #1 "Analytical Guru" in The Cannabis Scientist's 2020 Power List and was ranked among the top 5 "Analytical Heroes" in The Cannabis Scientist's 2021 Power List.
Chairman of the Board

John Bell

John is the Chairman at Stack Capital, a TSX (Canada) listed company. John is also the former Chairman of Canopy Growth Corp, Riv Capital, Shred-Tech, ATS, PolymerPlainfield, BSM and Cure Pharmaceuticals.

Chief Business Development Officer

Grace Marr

Grace spearheads global business development for the Company and she has driven the Company’s expansion into Brazil, the US and other major markets to come. Grace is also a founder of the “Respect” brand, and a serial entrepreneur in product development, as well as commercial and residential design.

Chief of Production

Kurt Dietenhofer

Kurt has guided the development of the pharma facility and runs all production for the Company. Formerly he was the Chief of Production for Jetty Extracts in California, and the Operations Manager for PerkinElmer. Previously he was also involved in stem cell and vaccine research, managing production and supporting R&D and assay activities.

Director & Co-Founder

Martin Shefsky

Based in Toronto, Martin was the Founder and Executive Director of 48 North (f/k/a Delshen Therapeutics), the 39th Licensed Producer in Canada, which he took public before it was bought by Hexo and subsequently absorbed into Tilray.

Mission & Vision

Deliver efficacious products with real, tangible benefits for patients.

Simply put, we make medicines and products that work.

01

Operate with the highest level of integrity in every way.

We aim to make the right choices, for the right reasons, every time.

02

Leave the world a better place than you find it.

We seek to improve the lives of patients and help improve global human health along the way.

03

Close Menu
19-20 Bogue Industrial Estates, Montego Bay, Jamaica
pt_BRPortuguês do Brasil